Contribution: Industrial Research Assistance Program – Contributions to Firms
Precision BioLogic Incorporated
$249,465.00
Development of Innovative Solutions for Detection of Antibody Biomarkers for Hemostasis and Oncology Disease States
FY 2020-21 · 2020-09-01
Summary
This project will involve the pursuit of research and development efforts to result in new and innovative solutions for detection of antibody biomarkers associated with disease states in hemostasis and cancer. The underlying technology necessary to adapt immunoassays to common coagulation assay platforms will be developed, resulting in a rapid, automated immunoassay technology, with a first application as a hemostasis biomarker IVD device. In parallel, a competitive ELISA format immunoassay will be developed for the detection of an emerging cancer biomarker, which can in the future be adapted to the rapid immunoassay technology and enable Precision Biologic’s entry into new market segments.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Dartmouth|Dartmouth, Nova Scotia, Canada
Recipient Type
For-profit organization
Business Number
104288360
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-09-01 | 2020-21 | $405,439.00 |
| 3 | 2020-09-01 | 2020-21 | $385,001.00 |
| 4 | 2020-09-01 | 2020-21 | $187,415.00 |
| 5 | 2020-09-01 | 2020-21 | $259,465.00 |
| 6 | 2020-09-01 | 2020-21 | $249,465.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is -10,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de - 10 000 dollars.
Agreement End Date
2024-03-31
Agreement Number
957087
Agreement Start Date
2020-09-01
Agreement Title
Development of Innovative Solutions for Detection of Antibody Biomarkers for Hemostasis and Oncology Disease States
Agreement Title (French)
Élaboration de solutions innovantes pour la détection de biomarqueurs d'anticorps pour les états hémostatiques et oncologiques
Agreement Type
Contribution
Agreement Value
$249,465.00
Amendment Date
2024-03-05
Amendment Number
6
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will involve the pursuit of research and development efforts to result in new and innovative solutions for detection of antibody biomarkers associated with disease states in hemostasis and cancer. The underlying technology necessary to adapt immunoassays to common coagulation assay platforms will be developed, resulting in a rapid, automated immunoassay technology, with a first application as a hemostasis biomarker IVD device. In parallel, a competitive ELISA format immunoassay will be developed for the detection of an emerging cancer biomarker, which can in the future be adapted to the rapid immunoassay technology and enable Precision Biologic’s entry into new market segments.
Description (French)
Ce projet comportera la poursuite des efforts de recherche et de développement pour aboutir à des solutions nouvelles et innovantes pour la détection des biomarqueurs d'anticorps associés aux états pathologiques dans l'hémostase et le cancer. La technologie sous-jacente nécessaire à l'adaptation des immunoessais aux plates-formes courantes de tests de coagulation sera conçue, ce qui permettra d'obtenir une technologie d'immunoessais rapide et automatisée, avec une première application en tant que dispositif de DIV de biomarqueurs d'hémostase. En parallèle, un immunoessai concurrentiel au format ELISA sera mis au point pour la détection d'un nouveau biomarqueur du cancer, qui pourra à l'avenir être adapté à la technologie d'immunoessais rapide et permettre à Precision Biologic d'entrer dans de nouveaux segments de marché.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Dartmouth--Cole Harbour
Federal Riding (French)
Dartmouth--Cole Harbour
Federal Riding Number
12004
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
104288360
Recipient City
Dartmouth|Dartmouth
Recipient Country
CA
Recipient Legal Name
Precision BioLogic Incorporated
Recipient Operating Name
Precision BioLogic
Recipient Postal Code
B3B 0A9
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2020-2021-Q2-957087
